PSB-0739

• UNSPSC Description:

  PSB-0739 is a high-affinity potent, competitive, nonselective platelet P2Y12 receptor antagonist with a Ki values of 24.9 nM. The P2Y12 receptor plays a crucial role in platelet aggregation. Antithrombotic effect[1].

• Target Antigen:

  P2Y Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/psb-0739.html

• Purity:

  98.0

• Solubility:

  H2O : 3.33 mg/mL (ultrasonic)

• Smiles:

  O=S(C(C(N)=C1C2=O)=CC(NC3=CC=C(NC4=CC=CC=C4)C(S(=O)(O[Na])=O)=C3)=C1C(C5=C2C=CC=C5)=O)(O[Na])=O

• Molecular Weight:

  609.54

• References & Citations:

  [1]Younis Baqi, et al. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y₁₂ receptors. J Med Chem. 2009 Jun 25;52(12):3784-93.|[2]Kristina Hoffmann, et al. Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y₁₂ receptor. J Pharmacol Exp Ther. 2009 Nov;331(2):648-55.|[3]J J Micklewright,et al. P2Y 12 receptor modulation of ADP-evoked intracellular Ca²⁺ signalling in THP-1 human monocytic cells. Br J Pharmacol.2018 Jun;175(12):2483-2491.|[4]Gergely Horváth, et al. Central P2Y₁₂ receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiol Dis. 2014 Oct;70(100):162-78.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  1052087-90-7